Skip to main content
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
12.46
-5.48 (-30.54%)
At close: Apr 28, 2026, 4:00 PM EDT
13.57
+1.12 (8.95%)
After-hours: Apr 28, 2026, 7:58 PM EDT

Cue Biopharma Revenue

In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth. Cue Biopharma had revenue of $21.94M in the quarter ending December 31, 2025, with 1,292.26% growth.

Revenue (ttm)
$27.47M
Revenue Growth
+195.75%
P/S Ratio
1.48
Revenue / Employee
$947,103
Employees
29
Market Cap
40.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202527.47M18.18M195.75%
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Metagenomi Therapeutics 25.21M
MindWalk Holdings 20.70M
Radiopharm Theranostics 10.86M
BeyondSpring 1.88M
ImageneBio 800.00K
iBio, Inc. 300.00K
Entera Bio 42.00K
Revenue Rankings

CUE News

More News